726 related articles for article (PubMed ID: 21750293)
1. Effect of bronchoalveolar lavage-directed therapy on Pseudomonas aeruginosa infection and structural lung injury in children with cystic fibrosis: a randomized trial.
Wainwright CE; Vidmar S; Armstrong DS; Byrnes CA; Carlin JB; Cheney J; Cooper PJ; Grimwood K; Moodie M; Robertson CF; Tiddens HA;
JAMA; 2011 Jul; 306(2):163-71. PubMed ID: 21750293
[TBL] [Abstract][Full Text] [Related]
2. Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.
Jain K; Wainwright C; Smyth AR
Cochrane Database Syst Rev; 2013 Dec; (12):CD009530. PubMed ID: 24363033
[TBL] [Abstract][Full Text] [Related]
3. Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.
Jain K; Wainwright C; Smyth AR
Cochrane Database Syst Rev; 2016 Jan; (1):CD009530. PubMed ID: 26797965
[TBL] [Abstract][Full Text] [Related]
4. Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.
Jain K; Wainwright CE; Smyth AR
Cochrane Database Syst Rev; 2024 May; 5(5):CD009530. PubMed ID: 38700027
[TBL] [Abstract][Full Text] [Related]
5. Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.
Jain K; Wainwright C; Smyth AR
Cochrane Database Syst Rev; 2018 Sep; 9(9):CD009530. PubMed ID: 30221745
[TBL] [Abstract][Full Text] [Related]
6. Pseudomonas aeruginosa genotypes acquired by children with cystic fibrosis by age 5-years.
Kidd TJ; Ramsay KA; Vidmar S; Carlin JB; Bell SC; Wainwright CE; Grimwood K;
J Cyst Fibros; 2015 May; 14(3):361-9. PubMed ID: 25563522
[TBL] [Abstract][Full Text] [Related]
7. The clinical significance of oropharyngeal cultures in young children with cystic fibrosis.
Breuer O; Caudri D; Akesson L; Ranganathan S; Stick SM; Schultz A;
Eur Respir J; 2018 May; 51(5):. PubMed ID: 29678944
[TBL] [Abstract][Full Text] [Related]
8. Costs of bronchoalveolar lavage-directed therapy in the first 5 years of life for children with cystic fibrosis.
Moodie M; Lal A; Vidmar S; Armstrong DS; Byrnes CA; Carlin JB; Cheney J; Cooper PJ; Grimwood K; Robertson CF; Tiddens HA; Wainwright CE;
J Pediatr; 2014 Sep; 165(3):564-569.e5. PubMed ID: 24996984
[TBL] [Abstract][Full Text] [Related]
9. Bronchoalveolar lavage-directed therapy in children with cystic fibrosis and Pseudomonas aeruginosa infection.
Linnane B; McNally P
JAMA; 2011 Oct; 306(16):1761; author reply 1761-2. PubMed ID: 22028348
[No Abstract] [Full Text] [Related]
10.
Harun SN; Wainwright CE; Grimwood K; Hennig S;
Thorax; 2019 Feb; 74(2):125-131. PubMed ID: 30275132
[TBL] [Abstract][Full Text] [Related]
11. Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial.
Saiman L; Anstead M; Mayer-Hamblett N; Lands LC; Kloster M; Hocevar-Trnka J; Goss CH; Rose LM; Burns JL; Marshall BC; Ratjen F;
JAMA; 2010 May; 303(17):1707-15. PubMed ID: 20442386
[TBL] [Abstract][Full Text] [Related]
12. Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis.
Armstrong DS; Grimwood K; Carlin JB; Carzino R; Olinsky A; Phelan PD
Pediatr Pulmonol; 1996 May; 21(5):267-75. PubMed ID: 8726151
[TBL] [Abstract][Full Text] [Related]
13.
Harun SN; Holford NHG; Grimwood K; Wainwright CE; Hennig S;
Thorax; 2019 Aug; 74(8):740-748. PubMed ID: 31203197
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis.
Li Z; Kosorok MR; Farrell PM; Laxova A; West SE; Green CG; Collins J; Rock MJ; Splaingard ML
JAMA; 2005 Feb; 293(5):581-8. PubMed ID: 15687313
[TBL] [Abstract][Full Text] [Related]
15. Acquisition and eradication of P. aeruginosa in young children with cystic fibrosis.
Douglas TA; Brennan S; Gard S; Berry L; Gangell C; Stick SM; Clements BS; Sly PD
Eur Respir J; 2009 Feb; 33(2):305-11. PubMed ID: 19010992
[TBL] [Abstract][Full Text] [Related]
16. Cyanide in bronchoalveolar lavage is not diagnostic for Pseudomonas aeruginosa in children with cystic fibrosis.
Stutz MD; Gangell CL; Berry LJ; Garratt LW; Sheil B; Sly PD;
Eur Respir J; 2011 Mar; 37(3):553-8. PubMed ID: 20562125
[TBL] [Abstract][Full Text] [Related]
17. Prospective evaluation of respiratory exacerbations in children with cystic fibrosis from newborn screening to 5 years of age.
Byrnes CA; Vidmar S; Cheney JL; Carlin JB; Armstrong DS; Cooper PJ; Grimwood K; Moodie M; Robertson CF; Rosenfeld M; Tiddens HA; Wainwright CE;
Thorax; 2013 Jul; 68(7):643-51. PubMed ID: 23345574
[TBL] [Abstract][Full Text] [Related]
18. Bronchiectases at early chest computed tomography in children with cystic fibrosis are associated with increased risk of subsequent pulmonary exacerbations and chronic pseudomonas infection.
Bortoluzzi CF; Volpi S; D'Orazio C; Tiddens HA; Loeve M; Tridello G; Assael BM
J Cyst Fibros; 2014 Sep; 13(5):564-71. PubMed ID: 24726420
[TBL] [Abstract][Full Text] [Related]
19. Induced sputum compared to bronchoalveolar lavage in young, non-expectorating cystic fibrosis children.
Blau H; Linnane B; Carzino R; Tannenbaum EL; Skoric B; Robinson PJ; Robertson C; Ranganathan SC
J Cyst Fibros; 2014 Jan; 13(1):106-10. PubMed ID: 23806622
[TBL] [Abstract][Full Text] [Related]
20. Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial.
Saiman L; Marshall BC; Mayer-Hamblett N; Burns JL; Quittner AL; Cibene DA; Coquillette S; Fieberg AY; Accurso FJ; Campbell PW;
JAMA; 2003 Oct; 290(13):1749-56. PubMed ID: 14519709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
